Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy

Abstract excerpt

BACKGROUND: Clustered Regularly Interspaced Short Palindromic Repeats-associated (CRISPR-Cas) technology may allow for efficient and highly targeted gene editing in single-cell embryos. This possibility brings human germline editing into the focus of ethical and legal debates again. MAIN BODY: Against this background, we explore essential ethical and legal questions of interventions into the human germline by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biotechnology and Related Fields
• Share to CRISPR and Genetic Engineering
• Share to Neuroethics, Human Enhancement, Biomedical Innovations